Bing

SEARCH HISTORY

Avanir Pharmaceuticals (AVNR, -20%): Shares AVNR stock got pounded on Wednesday, topping our list of biggest stock losers by opening to 20% or so gains. The reason AVNR stock investors headed for the door? Avanir Pharmaceuticals reported a fourth ...
Investor Place · 12/11/2013
NEW YORK (TheStreet) -- Shares of Avanir Pharmaceuticals (AVNR) are up 12.60% to $16.89 in pre-market trade after it was reported that Otsuka Holdings Co. agreed to buy the California-based company for about $3.54 billion, a deal that gives the …
The Street · 12/2/2014
Avanir Pharmaceuticals, Inc. (AVNR) saw a big move last session, as the company’s shares fell by nearly 7% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This stock, trading at a …
Yahoo Finance · 9/19/2014
More from Bing News
What: Shares of Avanir Pharmaceuticals (NASDAQ:AVNR.DL), a biopharmaceutical company focused on developing therapies to treat central nervous system disorders, leaped 14% higher in December, according to data from S&P Capital IQ, after agreeing …
The Motley Fool · BySean Williams · 1/6/2015
On Monday, small cap Avanir Pharmaceuticals surged 85.31% to $12.49 (AVNR has a 52 week trading range of $2.62 to $13.09 a share) for a market cap of $1.16 billion plus the stock is up 279.6% since the start of the year, up 206.1% over the past year …
Smallcap Network · ByJohn Udovich · 9/16/2014
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) has been in a strong uptrend on subdued volumes. The stock is trading above its 20-Day EMA of $13.48 with RSI in overbought zone at 79.14. Going forward the stock has support near $14.7 and $14.30 in near …
wallstreetpr.com · 11/27/2014
Avanir Pharmaceuticals, Inc. ( AVNR) saw a big move last session, as the company's shares fell by nearly 7% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This stock, trading at a …
NASDAQ · 9/19/2014
Avanir Pharmaceuticals Inc. (AVNR) has offered to sell 18.2 million shares of its common stock to the public at a price of $11 each. The underwriters have a 30-day option to purchase up to an additional 2.73 million shares in connection with the offering.
Realtime Business News · 9/24/2014
Looking back to 36 days ago, Avanir Pharmaceuticals Avanir Pharmaceuticals, Inc. (NASD: AVNR) priced a 18,200,000 share secondary stock offering at $11.00 per share. Buyers in that offering made a considerable investment into the company, expecting …
Forbes · 10/29/2014
We believe that AVNR stock will collapse in the near future due to the perfect storm of overhanging potential negative events threatening its solvency, including a sharp drop in future revenue and fines resulting from a potential illegal off-label ...
Seeking Alpha · 9/11/2013